

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.34927597 |
| 2 | regulation of cell communication by electrical coupling (GO:0010649) | 4.30738102 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.19816576 |
| 4 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.19763635 |
| 5 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.11444641 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.97453104 |
| 7 | negative regulation of protein localization to cell surface (GO:2000009) | 3.81004730 |
| 8 | muscle filament sliding (GO:0030049) | 3.79228431 |
| 9 | actin-myosin filament sliding (GO:0033275) | 3.79228431 |
| 10 | sarcomere organization (GO:0045214) | 3.77307343 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.75716855 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 3.71836722 |
| 13 | central nervous system myelination (GO:0022010) | 3.68296421 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 3.68296421 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.67002071 |
| 16 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.59659545 |
| 17 | plasma membrane repair (GO:0001778) | 3.56942900 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.55543026 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.55098654 |
| 20 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.53669462 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.50643501 |
| 22 | postsynaptic membrane organization (GO:0001941) | 3.46396487 |
| 23 | axonal fasciculation (GO:0007413) | 3.45280683 |
| 24 | presynaptic membrane organization (GO:0097090) | 3.44741363 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44640595 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.42975198 |
| 27 | cardiac myofibril assembly (GO:0055003) | 3.40150827 |
| 28 | regulation of actin filament-based movement (GO:1903115) | 3.37440269 |
| 29 | myofibril assembly (GO:0030239) | 3.36784093 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35209837 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.33151986 |
| 32 | regulation of membrane repolarization (GO:0060306) | 3.32696311 |
| 33 | synaptic vesicle exocytosis (GO:0016079) | 3.27895226 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.26070795 |
| 35 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.21335856 |
| 36 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.21335856 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.20238329 |
| 38 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.19763941 |
| 39 | vocalization behavior (GO:0071625) | 3.19162982 |
| 40 | regulation of skeletal muscle contraction (GO:0014819) | 3.13190328 |
| 41 | negative regulation of neurotransmitter transport (GO:0051589) | 3.11443237 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.11243337 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.09862215 |
| 44 | actin-mediated cell contraction (GO:0070252) | 3.08898412 |
| 45 | locomotory exploration behavior (GO:0035641) | 3.05468318 |
| 46 | cardiac muscle contraction (GO:0060048) | 3.05144816 |
| 47 | creatine metabolic process (GO:0006600) | 3.03858090 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.03123702 |
| 49 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.02259257 |
| 50 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.01065471 |
| 51 | detection of calcium ion (GO:0005513) | 3.00179455 |
| 52 | regulation of striated muscle contraction (GO:0006942) | 2.95935710 |
| 53 | potassium ion import (GO:0010107) | 2.95128080 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.92445736 |
| 55 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.91880421 |
| 56 | protein localization to synapse (GO:0035418) | 2.86240519 |
| 57 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.85487051 |
| 58 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.85456979 |
| 59 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.85112189 |
| 60 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.83891010 |
| 61 | nerve growth factor signaling pathway (GO:0038180) | 2.81277542 |
| 62 | cell communication involved in cardiac conduction (GO:0086065) | 2.81147725 |
| 63 | striated muscle contraction (GO:0006941) | 2.80988396 |
| 64 | nucleobase catabolic process (GO:0046113) | 2.80926583 |
| 65 | positive regulation of potassium ion transport (GO:0043268) | 2.80059945 |
| 66 | glutamate secretion (GO:0014047) | 2.79851475 |
| 67 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.78466290 |
| 68 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.78105070 |
| 69 | regulation of synaptic vesicle transport (GO:1902803) | 2.71383723 |
| 70 | regulation of cation channel activity (GO:2001257) | 2.70723469 |
| 71 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.70340099 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 2.70222361 |
| 73 | response to epinephrine (GO:0071871) | 2.68567934 |
| 74 | membrane depolarization during action potential (GO:0086010) | 2.68259974 |
| 75 | protein heterotrimerization (GO:0070208) | 2.66505257 |
| 76 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.66454719 |
| 77 | regulation of axon guidance (GO:1902667) | 2.65876309 |
| 78 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.65592858 |
| 79 | ganglion development (GO:0061548) | 2.65332982 |
| 80 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.64683609 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.63906909 |
| 82 | negative regulation of axon guidance (GO:1902668) | 2.63491055 |
| 83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.63294546 |
| 84 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.63294546 |
| 85 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.63220940 |
| 86 | activation of protein kinase A activity (GO:0034199) | 2.63153141 |
| 87 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.62488581 |
| 88 | neuron recognition (GO:0008038) | 2.62458343 |
| 89 | skeletal muscle contraction (GO:0003009) | 2.61844561 |
| 90 | regulation of coenzyme metabolic process (GO:0051196) | 2.61240175 |
| 91 | regulation of cofactor metabolic process (GO:0051193) | 2.61240175 |
| 92 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.60620279 |
| 93 | membrane tubulation (GO:0097320) | 2.59898915 |
| 94 | cellular response to epinephrine stimulus (GO:0071872) | 2.59764019 |
| 95 | muscle cell cellular homeostasis (GO:0046716) | 2.58462609 |
| 96 | actomyosin structure organization (GO:0031032) | 2.56724554 |
| 97 | establishment of mitochondrion localization (GO:0051654) | 2.56430696 |
| 98 | retinal ganglion cell axon guidance (GO:0031290) | 2.55925473 |
| 99 | tricarboxylic acid cycle (GO:0006099) | 2.54610262 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.53921349 |
| 101 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.53168776 |
| 102 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.53065711 |
| 103 | positive regulation of cation channel activity (GO:2001259) | 2.52239831 |
| 104 | axon extension (GO:0048675) | 2.51868015 |
| 105 | glutamate receptor signaling pathway (GO:0007215) | 2.51795291 |
| 106 | myelination (GO:0042552) | 2.51376966 |
| 107 | actin filament-based movement (GO:0030048) | 2.49881011 |
| 108 | presynaptic membrane assembly (GO:0097105) | 2.48969461 |
| 109 | axon ensheathment (GO:0008366) | 2.48902716 |
| 110 | ensheathment of neurons (GO:0007272) | 2.48902716 |
| 111 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.48617878 |
| 112 | membrane assembly (GO:0071709) | 2.47254997 |
| 113 | cerebellar granule cell differentiation (GO:0021707) | 2.47129509 |
| 114 | electron transport chain (GO:0022900) | 2.47020900 |
| 115 | cellular potassium ion homeostasis (GO:0030007) | 2.46051024 |
| 116 | paraxial mesoderm development (GO:0048339) | 2.45731353 |
| 117 | regulation of sarcomere organization (GO:0060297) | 2.45659309 |
| 118 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45104738 |
| 119 | regulation of synapse assembly (GO:0051963) | 2.43269598 |
| 120 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.40324205 |
| 121 | metanephric mesenchyme development (GO:0072075) | 2.39635296 |
| 122 | positive regulation of synapse assembly (GO:0051965) | 2.39403632 |
| 123 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.39350078 |
| 124 | dendritic spine morphogenesis (GO:0060997) | 2.37616647 |
| 125 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.37047650 |
| 126 | axon extension involved in axon guidance (GO:0048846) | 2.35603280 |
| 127 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.35603280 |
| 128 | neuromuscular synaptic transmission (GO:0007274) | 2.34954242 |
| 129 | kidney mesenchyme development (GO:0072074) | 2.33430106 |
| 130 | negative chemotaxis (GO:0050919) | 2.30445218 |
| 131 | collagen fibril organization (GO:0030199) | 2.29569599 |
| 132 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.29131774 |
| 133 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.19864236 |
| 134 | chondrocyte proliferation (GO:0035988) | 2.13742090 |
| 135 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.12927187 |
| 136 | auditory behavior (GO:0031223) | 2.12538679 |
| 137 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.12277509 |
| 138 | synapse assembly (GO:0007416) | 2.11274793 |
| 139 | cerebral cortex cell migration (GO:0021795) | 2.10787500 |
| 140 | response to redox state (GO:0051775) | 2.09148381 |
| 141 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.09139870 |
| 142 | C4-dicarboxylate transport (GO:0015740) | 2.08425928 |
| 143 | response to gravity (GO:0009629) | 2.07557158 |
| 144 | lymphangiogenesis (GO:0001946) | 2.06468499 |
| 145 | myoblast fusion (GO:0007520) | 2.05679409 |
| 146 | regulation of dendritic spine development (GO:0060998) | 2.05341593 |
| 147 | dendrite morphogenesis (GO:0048813) | 2.03867308 |
| 148 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.03167785 |
| 149 | fibroblast migration (GO:0010761) | 2.01695485 |
| 150 | positive regulation of actin filament depolymerization (GO:0030836) | 2.01324844 |
| 151 | positive regulation of protein depolymerization (GO:1901881) | 2.00689875 |
| 152 | * cardiac muscle cell development (GO:0055013) | 2.00626797 |
| 153 | response to inactivity (GO:0014854) | 2.00192923 |
| 154 | neuron projection extension (GO:1990138) | 2.00103542 |
| 155 | limb bud formation (GO:0060174) | 1.97659154 |
| 156 | glycosphingolipid biosynthetic process (GO:0006688) | 1.94522619 |
| 157 | positive regulation of mitochondrial fission (GO:0090141) | 1.94325992 |
| 158 | olfactory bulb development (GO:0021772) | 1.94190741 |
| 159 | negative regulation of axon extension (GO:0030517) | 1.93141308 |
| 160 | nonmotile primary cilium assembly (GO:0035058) | 1.92335555 |
| 161 | synapse organization (GO:0050808) | 1.92275121 |
| 162 | appendage development (GO:0048736) | 1.91724090 |
| 163 | limb development (GO:0060173) | 1.91724090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.93977489 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01743572 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.97113702 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93669340 |
| 5 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.63686670 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63540027 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.53799781 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.53799781 |
| 9 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38814352 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37874184 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34553787 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25505048 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.23776329 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21493804 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.21096633 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.11076509 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07507081 |
| 18 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07172976 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04880609 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98724599 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95003563 |
| 22 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90782552 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.87157274 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83404497 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82118985 |
| 26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80109134 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.75963736 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75949646 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70951556 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69983145 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69491140 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67964606 |
| 33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.65179925 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58324782 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56067357 |
| 36 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55851576 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53350352 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52993044 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52544075 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50966922 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50338837 |
| 42 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50234678 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49746976 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49376533 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48255585 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41148689 |
| 47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37653485 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36780528 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35878170 |
| 50 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.33549100 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33228556 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32683933 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32626754 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32317557 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31284129 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29411437 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28998654 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28389696 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27509778 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27285945 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27111410 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25755931 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24849569 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24705339 |
| 65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23991671 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23478757 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22458460 |
| 68 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.20082362 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19840105 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19840105 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16867401 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16420388 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16090899 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14291485 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13743738 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13148043 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12646322 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12600182 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11406484 |
| 80 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10482011 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10392009 |
| 82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10315747 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10270394 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10048251 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09736441 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09377936 |
| 87 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.09128319 |
| 88 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08903898 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08684333 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08619430 |
| 91 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08455976 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08429854 |
| 93 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07824873 |
| 94 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06993077 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06855762 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06391064 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05959068 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05959068 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05700916 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 1.05618518 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04914042 |
| 102 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04643467 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04417571 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04055637 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02279148 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00856630 |
| 107 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98111796 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97346563 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96922585 |
| 110 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96578378 |
| 111 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96034539 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96011990 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95142943 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94594721 |
| 115 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93908026 |
| 116 | AR_19668381_ChIP-Seq_PC3_Human | 0.93860420 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92990056 |
| 118 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91466481 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91448560 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91021028 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90937901 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89999518 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89463174 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89463174 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86760825 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84826057 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83794064 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81313333 |
| 129 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80984700 |
| 130 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.80919758 |
| 131 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80729705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.95024407 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.77019511 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.68069435 |
| 4 | * MP0000749_muscle_degeneration | 3.21055614 |
| 5 | MP0004270_analgesia | 3.15644961 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.10111210 |
| 7 | MP0003646_muscle_fatigue | 2.86553107 |
| 8 | MP0003880_abnormal_central_pattern | 2.78221952 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.69056723 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.50154493 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.45610414 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.44237404 |
| 13 | MP0009745_abnormal_behavioral_response | 2.16135837 |
| 14 | MP0002064_seizures | 2.09780353 |
| 15 | MP0000747_muscle_weakness | 2.05965463 |
| 16 | MP0004272_abnormal_basement_membrane | 1.96345283 |
| 17 | MP0002272_abnormal_nervous_system | 1.96147018 |
| 18 | * MP0005330_cardiomyopathy | 1.89960233 |
| 19 | MP0009046_muscle_twitch | 1.87651780 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 1.87602564 |
| 21 | * MP0002106_abnormal_muscle_physiology | 1.86900997 |
| 22 | MP0004130_abnormal_muscle_cell | 1.83828464 |
| 23 | MP0003137_abnormal_impulse_conducting | 1.83252433 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.82505459 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.81196963 |
| 26 | MP0003329_amyloid_beta_deposits | 1.79069435 |
| 27 | MP0000920_abnormal_myelination | 1.76921126 |
| 28 | * MP0004087_abnormal_muscle_fiber | 1.75505383 |
| 29 | MP0004858_abnormal_nervous_system | 1.73158563 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.69934289 |
| 31 | * MP0005369_muscle_phenotype | 1.68828463 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.65139827 |
| 33 | MP0004484_altered_response_of | 1.63495617 |
| 34 | MP0002972_abnormal_cardiac_muscle | 1.63365576 |
| 35 | MP0001486_abnormal_startle_reflex | 1.63210354 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.62968814 |
| 37 | MP0008569_lethality_at_weaning | 1.61407168 |
| 38 | * MP0000759_abnormal_skeletal_muscle | 1.58833677 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.58398458 |
| 40 | MP0005275_abnormal_skin_tensile | 1.56159365 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.55201530 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.54290848 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.49844446 |
| 44 | MP0004085_abnormal_heartbeat | 1.49657477 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.44836670 |
| 46 | * MP0002269_muscular_atrophy | 1.43225035 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.43174490 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.42931002 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.38139292 |
| 50 | MP0004233_abnormal_muscle_weight | 1.36743307 |
| 51 | MP0000534_abnormal_ureter_morphology | 1.35943216 |
| 52 | MP0002736_abnormal_nociception_after | 1.34823493 |
| 53 | MP0001970_abnormal_pain_threshold | 1.33755827 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.31995288 |
| 55 | MP0004142_abnormal_muscle_tone | 1.31673790 |
| 56 | MP0003122_maternal_imprinting | 1.31669436 |
| 57 | MP0004924_abnormal_behavior | 1.30458750 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.30458750 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.29785256 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.29691217 |
| 61 | MP0002102_abnormal_ear_morphology | 1.28754116 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.28735348 |
| 63 | MP0003283_abnormal_digestive_organ | 1.28051624 |
| 64 | MP0000778_abnormal_nervous_system | 1.28036951 |
| 65 | MP0003634_abnormal_glial_cell | 1.27953930 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.26371901 |
| 67 | MP0001529_abnormal_vocalization | 1.23845814 |
| 68 | MP0005423_abnormal_somatic_nervous | 1.22042115 |
| 69 | MP0002822_catalepsy | 1.21930547 |
| 70 | MP0001542_abnormal_bone_strength | 1.20827814 |
| 71 | MP0006054_spinal_hemorrhage | 1.20333683 |
| 72 | MP0005171_absent_coat_pigmentation | 1.20236504 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.19082047 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 1.18587452 |
| 75 | MP0010030_abnormal_orbit_morphology | 1.16853934 |
| 76 | MP0002295_abnormal_pulmonary_circulatio | 1.15256588 |
| 77 | MP0003755_abnormal_palate_morphology | 1.14089433 |
| 78 | * MP0002108_abnormal_muscle_morphology | 1.13725521 |
| 79 | MP0002638_abnormal_pupillary_reflex | 1.13027525 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.12922107 |
| 81 | MP0003950_abnormal_plasma_membrane | 1.11863018 |
| 82 | MP0005385_cardiovascular_system_phenoty | 1.11513539 |
| 83 | MP0001544_abnormal_cardiovascular_syste | 1.11513539 |
| 84 | MP0001905_abnormal_dopamine_level | 1.11449421 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.11383784 |
| 86 | MP0002184_abnormal_innervation | 1.10559400 |
| 87 | MP0003385_abnormal_body_wall | 1.08305263 |
| 88 | MP0003690_abnormal_glial_cell | 1.07228831 |
| 89 | MP0005187_abnormal_penis_morphology | 1.06978043 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.06929165 |
| 91 | MP0002233_abnormal_nose_morphology | 1.05770574 |
| 92 | MP0006138_congestive_heart_failure | 1.05748765 |
| 93 | MP0000049_abnormal_middle_ear | 1.04948775 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 1.04505228 |
| 95 | MP0000516_abnormal_urinary_system | 1.04505228 |
| 96 | MP0001299_abnormal_eye_distance/ | 1.04398959 |
| 97 | MP0001958_emphysema | 1.04066130 |
| 98 | MP0000955_abnormal_spinal_cord | 1.03737150 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 1.02762667 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 1.02388475 |
| 101 | MP0004885_abnormal_endolymph | 1.01515722 |
| 102 | MP0002882_abnormal_neuron_morphology | 1.00598159 |
| 103 | MP0003633_abnormal_nervous_system | 0.99800218 |
| 104 | MP0002938_white_spotting | 0.98519881 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.97901952 |
| 106 | MP0000733_abnormal_muscle_development | 0.97770539 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.97419513 |
| 108 | MP0003942_abnormal_urinary_system | 0.95534929 |
| 109 | * MP0003279_aneurysm | 0.95270139 |
| 110 | MP0004134_abnormal_chest_morphology | 0.95101901 |
| 111 | MP0004811_abnormal_neuron_physiology | 0.93806480 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.91976102 |
| 113 | MP0009697_abnormal_copulation | 0.91613648 |
| 114 | MP0004742_abnormal_vestibular_system | 0.91498847 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.90950051 |
| 116 | MP0005508_abnormal_skeleton_morphology | 0.90264144 |
| 117 | MP0004133_heterotaxia | 0.89927679 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.89766795 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.88066388 |
| 120 | MP0004043_abnormal_pH_regulation | 0.86956758 |
| 121 | MP0005253_abnormal_eye_physiology | 0.85992422 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.85819288 |
| 123 | MP0010630_abnormal_cardiac_muscle | 0.85275905 |
| 124 | MP0003631_nervous_system_phenotype | 0.83388619 |
| 125 | MP0002557_abnormal_social/conspecific_i | 0.82808941 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.82654056 |
| 127 | MP0003136_yellow_coat_color | 0.82289624 |
| 128 | MP0002229_neurodegeneration | 0.82279594 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.82072461 |
| 130 | MP0005646_abnormal_pituitary_gland | 0.74289706 |
| 131 | MP0001984_abnormal_olfaction | 0.74079309 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.73739332 |
| 133 | * MP0004510_myositis | 0.72696554 |
| 134 | MP0004147_increased_porphyrin_level | 0.69711519 |
| 135 | MP0001485_abnormal_pinna_reflex | 0.69686919 |
| 136 | MP0005409_darkened_coat_color | 0.68939836 |
| 137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68745721 |
| 138 | MP0000604_amyloidosis | 0.67813652 |
| 139 | MP0005165_increased_susceptibility_to | 0.67796832 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.67110166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.24604578 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.84474938 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 4.69240736 |
| 4 | Sudden death (HP:0001699) | 4.30985510 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 4.29724388 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.16449564 |
| 7 | * Abnormality of the calf musculature (HP:0001430) | 4.01115982 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 3.97677571 |
| 9 | Myokymia (HP:0002411) | 3.90152314 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 3.83183781 |
| 11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.80195904 |
| 12 | Focal motor seizures (HP:0011153) | 3.66553325 |
| 13 | Difficulty running (HP:0009046) | 3.58767881 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 3.58421970 |
| 15 | Nemaline bodies (HP:0003798) | 3.47746221 |
| 16 | Atrial fibrillation (HP:0005110) | 3.44820016 |
| 17 | Myotonia (HP:0002486) | 3.33163291 |
| 18 | Pheochromocytoma (HP:0002666) | 3.29427956 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.27766960 |
| 20 | Primary atrial arrhythmia (HP:0001692) | 3.23637969 |
| 21 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23424904 |
| 22 | Supraventricular tachycardia (HP:0004755) | 3.15046193 |
| 23 | Premature rupture of membranes (HP:0001788) | 3.15028474 |
| 24 | Supraventricular arrhythmia (HP:0005115) | 3.06886497 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.05298958 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99667193 |
| 27 | Prolonged QT interval (HP:0001657) | 2.97216796 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 2.87553176 |
| 29 | Myoglobinuria (HP:0002913) | 2.85782407 |
| 30 | Broad-based gait (HP:0002136) | 2.83207474 |
| 31 | Foot dorsiflexor weakness (HP:0009027) | 2.74440152 |
| 32 | Ventricular tachycardia (HP:0004756) | 2.72209434 |
| 33 | Syncope (HP:0001279) | 2.69084652 |
| 34 | Calcaneovalgus deformity (HP:0001848) | 2.68544930 |
| 35 | Delayed gross motor development (HP:0002194) | 2.68260821 |
| 36 | Protrusio acetabuli (HP:0003179) | 2.64861672 |
| 37 | Focal seizures (HP:0007359) | 2.64588056 |
| 38 | Gowers sign (HP:0003391) | 2.63214175 |
| 39 | Abnormality of the foot musculature (HP:0001436) | 2.62978750 |
| 40 | Round ear (HP:0100830) | 2.62689147 |
| 41 | Visual hallucinations (HP:0002367) | 2.62441535 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.60597230 |
| 43 | Muscle stiffness (HP:0003552) | 2.57781829 |
| 44 | Deformed tarsal bones (HP:0008119) | 2.56848033 |
| 45 | Atonic seizures (HP:0010819) | 2.53412733 |
| 46 | Distal arthrogryposis (HP:0005684) | 2.53046505 |
| 47 | Termporal pattern (HP:0011008) | 2.50314978 |
| 48 | Insidious onset (HP:0003587) | 2.50314978 |
| 49 | Lipoatrophy (HP:0100578) | 2.48174352 |
| 50 | Ankle clonus (HP:0011448) | 2.47667950 |
| 51 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46717942 |
| 52 | Subaortic stenosis (HP:0001682) | 2.46717942 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.43430290 |
| 54 | Clumsiness (HP:0002312) | 2.41715522 |
| 55 | Fetal akinesia sequence (HP:0001989) | 2.40527754 |
| 56 | Bundle branch block (HP:0011710) | 2.39368570 |
| 57 | Spinal rigidity (HP:0003306) | 2.32552361 |
| 58 | Slender build (HP:0001533) | 2.32135904 |
| 59 | Increased connective tissue (HP:0009025) | 2.32078181 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.31302857 |
| 61 | Action tremor (HP:0002345) | 2.30896062 |
| 62 | Soft skin (HP:0000977) | 2.28672907 |
| 63 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.28552674 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.28552674 |
| 65 | Follicular hyperkeratosis (HP:0007502) | 2.28103124 |
| 66 | Vascular tortuosity (HP:0004948) | 2.28047879 |
| 67 | Epileptic encephalopathy (HP:0200134) | 2.27584186 |
| 68 | Neck muscle weakness (HP:0000467) | 2.27033102 |
| 69 | Abnormality of dentin (HP:0010299) | 2.21565007 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.19668734 |
| 71 | Dysmetria (HP:0001310) | 2.18847791 |
| 72 | Ankle contracture (HP:0006466) | 2.18667506 |
| 73 | Aortic dissection (HP:0002647) | 2.18209587 |
| 74 | Wrist flexion contracture (HP:0001239) | 2.16954105 |
| 75 | Abnormal EKG (HP:0003115) | 2.16859342 |
| 76 | Left ventricular hypertrophy (HP:0001712) | 2.12906090 |
| 77 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12807411 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.12779384 |
| 79 | Nonprogressive disorder (HP:0003680) | 2.12669358 |
| 80 | * Dilated cardiomyopathy (HP:0001644) | 2.10965791 |
| 81 | Dysdiadochokinesis (HP:0002075) | 2.09129890 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.07480858 |
| 83 | Limited hip movement (HP:0008800) | 2.07054431 |
| 84 | Rapidly progressive (HP:0003678) | 2.06501704 |
| 85 | Abnormality of the corticospinal tract (HP:0002492) | 2.06413923 |
| 86 | Difficulty climbing stairs (HP:0003551) | 2.06331197 |
| 87 | Ventricular arrhythmia (HP:0004308) | 2.05410120 |
| 88 | Ulnar deviation of the wrist (HP:0003049) | 2.05202415 |
| 89 | Hip contracture (HP:0003273) | 2.03885362 |
| 90 | Aortic aneurysm (HP:0004942) | 2.02727111 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.02067644 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01940043 |
| 93 | Myopathic facies (HP:0002058) | 2.00052486 |
| 94 | Rimmed vacuoles (HP:0003805) | 1.99385210 |
| 95 | Hemiparesis (HP:0001269) | 1.99193332 |
| 96 | Neonatal short-limb short stature (HP:0008921) | 1.97553320 |
| 97 | Abnormal finger flexion creases (HP:0006143) | 1.94587392 |
| 98 | Steppage gait (HP:0003376) | 1.93242371 |
| 99 | Heart block (HP:0012722) | 1.92803506 |
| 100 | Gait imbalance (HP:0002141) | 1.92129967 |
| 101 | Muscular dystrophy (HP:0003560) | 1.90121612 |
| 102 | Arterial tortuosity (HP:0005116) | 1.89201822 |
| 103 | Infantile muscular hypotonia (HP:0008947) | 1.89079854 |
| 104 | Urinary urgency (HP:0000012) | 1.88807524 |
| 105 | Cerebral hemorrhage (HP:0001342) | 1.88648302 |
| 106 | * Limb-girdle muscle weakness (HP:0003325) | 1.88135442 |
| 107 | Scanning speech (HP:0002168) | 1.87594989 |
| 108 | Anxiety (HP:0000739) | 1.86246503 |
| 109 | Absence seizures (HP:0002121) | 1.86107368 |
| 110 | Abnormal atrioventricular conduction (HP:0005150) | 1.85763277 |
| 111 | Progressive macrocephaly (HP:0004481) | 1.85694563 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.84447061 |
| 113 | Generalized tonic-clonic seizures (HP:0002069) | 1.84309025 |
| 114 | Bladder diverticulum (HP:0000015) | 1.84305195 |
| 115 | Progressive inability to walk (HP:0002505) | 1.83211778 |
| 116 | Blue irides (HP:0000635) | 1.83003070 |
| 117 | Akinesia (HP:0002304) | 1.82694226 |
| 118 | Febrile seizures (HP:0002373) | 1.82130012 |
| 119 | Popliteal pterygium (HP:0009756) | 1.81888015 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81614144 |
| 121 | * Scapular winging (HP:0003691) | 1.81528980 |
| 122 | Megalencephaly (HP:0001355) | 1.81336755 |
| 123 | Medial flaring of the eyebrow (HP:0010747) | 1.81219030 |
| 124 | Atrophic scars (HP:0001075) | 1.80836896 |
| 125 | Shallow orbits (HP:0000586) | 1.79342715 |
| 126 | Progressive cerebellar ataxia (HP:0002073) | 1.79076923 |
| 127 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78750048 |
| 128 | Hypoventilation (HP:0002791) | 1.78262610 |
| 129 | Dialeptic seizures (HP:0011146) | 1.77959955 |
| 130 | Breech presentation (HP:0001623) | 1.76863705 |
| 131 | Palpitations (HP:0001962) | 1.76583126 |
| 132 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.75366354 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.73593139 |
| 134 | Congenital primary aphakia (HP:0007707) | 1.73581978 |
| 135 | Bowel diverticulosis (HP:0005222) | 1.72803207 |
| 136 | Onion bulb formation (HP:0003383) | 1.72534218 |
| 137 | Broad metatarsal (HP:0001783) | 1.72271740 |
| 138 | Overgrowth (HP:0001548) | 1.67491784 |
| 139 | Coronal craniosynostosis (HP:0004440) | 1.67003397 |
| 140 | Drooling (HP:0002307) | 1.64558701 |
| 141 | Abnormality of the ischium (HP:0003174) | 1.59155864 |
| 142 | Poor suck (HP:0002033) | 1.58133675 |
| 143 | Fatigable weakness (HP:0003473) | 1.57122584 |
| 144 | Abnormality of the neuromuscular junction (HP:0003398) | 1.57122584 |
| 145 | Genital tract atresia (HP:0001827) | 1.55904935 |
| 146 | Keratoconus (HP:0000563) | 1.54985321 |
| 147 | Increased corneal curvature (HP:0100692) | 1.54985321 |
| 148 | Nephrogenic diabetes insipidus (HP:0009806) | 1.53795336 |
| 149 | Wide anterior fontanel (HP:0000260) | 1.51871690 |
| 150 | Limb dystonia (HP:0002451) | 1.51483569 |
| 151 | Weak cry (HP:0001612) | 1.51341859 |
| 152 | Decreased muscle mass (HP:0003199) | 1.50168622 |
| 153 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.48773175 |
| 154 | Vaginal atresia (HP:0000148) | 1.48654406 |
| 155 | Intestinal atresia (HP:0011100) | 1.47588710 |
| 156 | Hypoplastic ischia (HP:0003175) | 1.47305295 |
| 157 | Shoulder girdle muscle weakness (HP:0003547) | 1.46907404 |
| 158 | Aplasia of the musculature (HP:0100854) | 1.46686674 |
| 159 | Hyperventilation (HP:0002883) | 1.41045181 |
| 160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.36188465 |
| 161 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 1.35580795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 3.47758715 |
| 2 | PHKG1 | 3.47758715 |
| 3 | MUSK | 3.29406409 |
| 4 | OBSCN | 2.72310837 |
| 5 | TTN | 2.71532567 |
| 6 | CAMKK2 | 2.64255223 |
| 7 | EPHA4 | 2.40530169 |
| 8 | NTRK3 | 2.32817808 |
| 9 | STK39 | 2.14034311 |
| 10 | LMTK2 | 2.04466230 |
| 11 | MARK1 | 2.03394202 |
| 12 | EPHB1 | 1.95653243 |
| 13 | CASK | 1.83575251 |
| 14 | EPHB2 | 1.79599409 |
| 15 | MAP3K9 | 1.77773989 |
| 16 | FRK | 1.72308481 |
| 17 | WNK3 | 1.70519214 |
| 18 | MINK1 | 1.67205390 |
| 19 | NTRK1 | 1.66319988 |
| 20 | PAK6 | 1.60768964 |
| 21 | TRIM28 | 1.59594382 |
| 22 | MAP3K4 | 1.58250033 |
| 23 | PDK4 | 1.56442537 |
| 24 | PDK3 | 1.56442537 |
| 25 | MYLK | 1.53744156 |
| 26 | OXSR1 | 1.39930370 |
| 27 | STK38L | 1.37012016 |
| 28 | CAMKK1 | 1.36845618 |
| 29 | PAK3 | 1.36192385 |
| 30 | DMPK | 1.35629486 |
| 31 | NME1 | 1.30221317 |
| 32 | MAP4K2 | 1.27264412 |
| 33 | UHMK1 | 1.26227906 |
| 34 | WNK1 | 1.25332988 |
| 35 | WNK4 | 1.23909075 |
| 36 | BMPR1B | 1.23739797 |
| 37 | PRPF4B | 1.23592571 |
| 38 | MAP2K7 | 1.22231786 |
| 39 | PLK2 | 1.21780736 |
| 40 | MAP3K12 | 1.20492805 |
| 41 | PTK2B | 1.19270040 |
| 42 | CAMK2D | 1.17677731 |
| 43 | KSR2 | 1.17450133 |
| 44 | PDGFRA | 1.17289296 |
| 45 | ROCK2 | 1.16281213 |
| 46 | TNIK | 1.15393124 |
| 47 | CAMK2A | 1.15331428 |
| 48 | PKN1 | 1.14498084 |
| 49 | CSNK1G1 | 1.12318940 |
| 50 | PINK1 | 1.12150281 |
| 51 | MAP2K4 | 1.11348161 |
| 52 | CDK5 | 1.10264561 |
| 53 | ARAF | 1.09736710 |
| 54 | PIK3CA | 1.07672625 |
| 55 | CAMK2B | 1.05595776 |
| 56 | CDK19 | 1.03831558 |
| 57 | NTRK2 | 1.02893668 |
| 58 | CSNK1G3 | 1.02780144 |
| 59 | DYRK2 | 1.02407648 |
| 60 | LATS1 | 1.02130310 |
| 61 | DAPK2 | 0.98969139 |
| 62 | CSNK1A1L | 0.98726188 |
| 63 | TIE1 | 0.97573808 |
| 64 | GRK7 | 0.95584174 |
| 65 | LIMK1 | 0.95102788 |
| 66 | NEK9 | 0.94826581 |
| 67 | TESK1 | 0.94305226 |
| 68 | PTK2 | 0.94124860 |
| 69 | PRKCE | 0.91583689 |
| 70 | SGK223 | 0.91509874 |
| 71 | SGK494 | 0.91509874 |
| 72 | GRK5 | 0.90147792 |
| 73 | ERBB4 | 0.89922690 |
| 74 | PRKD3 | 0.89209629 |
| 75 | CAMK2G | 0.87152029 |
| 76 | NEK1 | 0.86676270 |
| 77 | STK11 | 0.86632493 |
| 78 | GRK1 | 0.83866527 |
| 79 | MAPK13 | 0.82543413 |
| 80 | EPHA3 | 0.81992605 |
| 81 | MAPKAPK5 | 0.81459947 |
| 82 | PDPK1 | 0.79902295 |
| 83 | MOS | 0.79063672 |
| 84 | CDK14 | 0.77535250 |
| 85 | STK24 | 0.75886404 |
| 86 | PNCK | 0.75588660 |
| 87 | AKT3 | 0.74273872 |
| 88 | PDK2 | 0.74240810 |
| 89 | CAMK1 | 0.72443954 |
| 90 | PDK1 | 0.72040634 |
| 91 | MET | 0.68575027 |
| 92 | MKNK2 | 0.68442361 |
| 93 | PRKCH | 0.67811668 |
| 94 | ADRBK1 | 0.67477724 |
| 95 | EIF2AK3 | 0.66371930 |
| 96 | CDK18 | 0.64869748 |
| 97 | ROCK1 | 0.64621731 |
| 98 | MAPK12 | 0.64552869 |
| 99 | NEK6 | 0.64340757 |
| 100 | PAK2 | 0.64134687 |
| 101 | BCR | 0.63887877 |
| 102 | CDK15 | 0.63749315 |
| 103 | PLK3 | 0.63241596 |
| 104 | PRKACB | 0.62818537 |
| 105 | PIK3CG | 0.62757641 |
| 106 | RIPK4 | 0.61298886 |
| 107 | KSR1 | 0.61234855 |
| 108 | RET | 0.60688428 |
| 109 | PRKCG | 0.60457056 |
| 110 | MAP3K13 | 0.58994003 |
| 111 | CCNB1 | 0.57645096 |
| 112 | STK38 | 0.57039411 |
| 113 | PRKD1 | 0.56264125 |
| 114 | DYRK1B | 0.55702582 |
| 115 | MAP3K7 | 0.55648804 |
| 116 | LATS2 | 0.53297366 |
| 117 | BMPR2 | 0.52947219 |
| 118 | PRKACA | 0.52894827 |
| 119 | FER | 0.52780670 |
| 120 | DYRK1A | 0.52344490 |
| 121 | RPS6KA2 | 0.52154146 |
| 122 | CDK11A | 0.51001699 |
| 123 | STK3 | 0.50976445 |
| 124 | TGFBR2 | 0.50738705 |
| 125 | TYRO3 | 0.50572276 |
| 126 | ILK | 0.50134569 |
| 127 | FES | 0.49923209 |
| 128 | SGK1 | 0.48290139 |
| 129 | INSRR | 0.47341457 |
| 130 | CSNK1G2 | 0.46605399 |
| 131 | FGFR2 | 0.46534188 |
| 132 | PRKG1 | 0.46142998 |
| 133 | ERBB3 | 0.45431638 |
| 134 | FGFR1 | 0.45334961 |
| 135 | STK16 | 0.44330774 |
| 136 | DAPK3 | 0.43363197 |
| 137 | DDR2 | 0.42575336 |
| 138 | CDC42BPA | 0.42470200 |
| 139 | PRKAA1 | 0.39378055 |
| 140 | ADRBK2 | 0.39345561 |
| 141 | DYRK3 | 0.38685300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.76870474 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34474300 |
| 3 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.28464655 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25803474 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16549151 |
| 6 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.11925208 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.03215474 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01492036 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.00332027 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99922226 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90797718 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88025818 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87347687 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.85474175 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.85360203 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.78489327 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.73906336 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72418926 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71899972 |
| 20 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.59885895 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59799521 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55861147 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.55266114 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.54454555 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.53746192 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50296495 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44827891 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.43728643 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43641639 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.43272444 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.42645223 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42397882 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41283532 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40477337 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.35951310 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.34419287 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33696227 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.28899976 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.27588313 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26684530 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.20548924 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17416329 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14600748 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14336460 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.12034394 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11928425 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08659731 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07517655 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.06866413 |
| 50 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.05732782 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04727795 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02338240 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00917945 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00088993 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99051119 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98905453 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95751267 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94664878 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94282101 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92292567 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91219941 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87356742 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82299436 |
| 64 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82236589 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81082693 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80603678 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80141260 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80065455 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79296672 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.79295171 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78543486 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74969680 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74316182 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73455806 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70840078 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70030605 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69902678 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69022741 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68380605 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67794664 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66920885 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65609428 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.64875851 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64672261 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64291105 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63980911 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63932664 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63242039 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63038672 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62817728 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62698843 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62364646 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61614484 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61443553 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.60091038 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59960049 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.59582266 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59158459 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59090524 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58894814 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58023939 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.57583605 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57032871 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56519973 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54983352 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54861361 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54672300 |
| 108 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53270831 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.51951280 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51527669 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49518030 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49405500 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.49398226 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48439896 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48326610 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.46791728 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.46772573 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.46310542 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45841544 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45663431 |
| 121 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45495918 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45331074 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44674652 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44018542 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43487170 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43011211 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42519999 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42221226 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41487360 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39916499 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38713454 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38022804 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37834550 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36648501 |

